The energy-generating membrane protein NADH dehydrogenase (NDH-2), a proposed antibacterial drug target (see “Inhibitors of type II NADH:menaquinone oxidoreductase represent a class of antitubercular drugs” Weinstein et al. 2005 [1]), was screened for modulators of activity in either detergent-solublised or lipid reconstituted (proteolipsome) form. Here we present an annotated list of compounds identified in a small-scale screen against NDH-2. The dataset contains information regarding the libraries screened, the identities of hit compounds and the physicochemical properties governing solubility and permeability. The implications of these data for future antibiotic discovery are discussed in our associated report, “Comparison of lipid and d...
Type-II NADH:quinone oxidoreductases (NDH-2s) are an important element of microbial pathogen electro...
A prerequisite for any rational drug design strategy is understanding the mode of protein-ligand int...
Dihydrodipicolinate Reductase (DHPR) is a potential anti-infective drug target. Chapter 1 described ...
AbstractThe energy-generating membrane protein NADH dehydrogenase (NDH-2), a proposed antibacterial ...
The energy-generating membrane protein NADH dehydrogenase (NDH-2), a proposed antibacterial drug tar...
Compounds that target energy generation in many bacterial pathogens are effective inhibitors of grow...
acetic acid bacteria; respiratory chain; NADH dehydrogenase; inhibitor; antibiotics. In bacterial me...
AbstractThe NADH:ubiquinone reductase (NDH-2) of Escherichia coli was expressed as a His-tagged prot...
AbstractMethicillin-resistant Staphylococcus aureus (MRSA) is currently one of the principal multipl...
All organisms require energy for critical life processes, starting from the unicellular prokaryotes ...
The emergence of multidrug-resistant pathogens necessitates the search for new antibiotics acting on...
Type II NADH:quinone oxidoreductase (NDH-2) plays a crucial role in the respiratory chains of many o...
SummaryThe emergence of multidrug-resistant pathogens necessitates the search for new antibiotics ac...
<i>Mycobacterium tuberculosis</i> (<i>MTb</i>) possesses two nonproton pumping type II NADH dehydrog...
Type II NADH dehydrogenase (NDH-2) is an essential component of electron transfer in many microbial ...
Type-II NADH:quinone oxidoreductases (NDH-2s) are an important element of microbial pathogen electro...
A prerequisite for any rational drug design strategy is understanding the mode of protein-ligand int...
Dihydrodipicolinate Reductase (DHPR) is a potential anti-infective drug target. Chapter 1 described ...
AbstractThe energy-generating membrane protein NADH dehydrogenase (NDH-2), a proposed antibacterial ...
The energy-generating membrane protein NADH dehydrogenase (NDH-2), a proposed antibacterial drug tar...
Compounds that target energy generation in many bacterial pathogens are effective inhibitors of grow...
acetic acid bacteria; respiratory chain; NADH dehydrogenase; inhibitor; antibiotics. In bacterial me...
AbstractThe NADH:ubiquinone reductase (NDH-2) of Escherichia coli was expressed as a His-tagged prot...
AbstractMethicillin-resistant Staphylococcus aureus (MRSA) is currently one of the principal multipl...
All organisms require energy for critical life processes, starting from the unicellular prokaryotes ...
The emergence of multidrug-resistant pathogens necessitates the search for new antibiotics acting on...
Type II NADH:quinone oxidoreductase (NDH-2) plays a crucial role in the respiratory chains of many o...
SummaryThe emergence of multidrug-resistant pathogens necessitates the search for new antibiotics ac...
<i>Mycobacterium tuberculosis</i> (<i>MTb</i>) possesses two nonproton pumping type II NADH dehydrog...
Type II NADH dehydrogenase (NDH-2) is an essential component of electron transfer in many microbial ...
Type-II NADH:quinone oxidoreductases (NDH-2s) are an important element of microbial pathogen electro...
A prerequisite for any rational drug design strategy is understanding the mode of protein-ligand int...
Dihydrodipicolinate Reductase (DHPR) is a potential anti-infective drug target. Chapter 1 described ...